Primate Erythrocyte (E) Complement Receptor (CR1) as an Anchor Site for Bispecific-Based Therapies to Clear Pathogens or Autoantibodies Safely from the Circulation

Overview of attention for article published in Journal of Hematotherapy & Stem Cell Research, October 1995

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#23 of 237)
High Attention Score compared to outputs of the same age (81st percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 7 patents

Readers on

mendeley: 3 Mendeley

So far, Altmetric has seen 7 patents that reference this research output.

HETERODIMERIC ANTIBODY FC-CONTAINING PROTEINS AND METHODS FOR PRODUCTION THEREOF

Application EP-4477668-A2

European Patent Office

18 Dec 2024

PRODUCTION OF HETERODIMERIC PROTEINS

Application WO-2013060867-A2

World Intellectual Property Organisation (WIPO)

02 May 2013

HETERODIMERIC ANTIBODY FC-CONTAINING PROTEINS AND METHODS FOR PRODUCTION THEREOF

Application WO-2011131746-A2

World Intellectual Property Organisation (WIPO)

27 Oct 2011

Complement mediated assays for in vivo and in vitro methods

Application EP-1921451-A3

European Patent Office

28 May 2008

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 3 additional patents.